Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent
      Biotech

      Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent

      August 1, 2022
      ObsEva Announces Corporate Updates
      Biotech

      ObsEva Announces Corporate Updates

      August 1, 2022
      Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan
      Biotech

      Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan

      August 1, 2022
      Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 4, 2022
      Biotech

      Iovance Biotherapeutics to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 4, 2022

      August 1, 2022
      Kura Oncology to Report Second Quarter 2022 Financial Results
      Biotech

      Kura Oncology to Report Second Quarter 2022 Financial Results

      August 1, 2022
      Cassava Sciences Responds to Media Reports
      Biotech

      Cassava Sciences Responds to Media Reports

      August 1, 2022
      Acutus Medical to Announce Second Quarter 2022 Financial Results
      Biotech

      Acutus Medical to Announce Second Quarter 2022 Financial Results

      August 1, 2022
      Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia
      Biotech

      Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia

      August 1, 2022
      Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
      Biotech

      Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022

      August 1, 2022
      European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries
      Biotech

      European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries

      August 1, 2022
      « 1 … 121 122 123 124 125 … 133 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026